Species : |
Sars-CoV-2 |
Source : |
HEK293 |
Protein Length : |
Arg 319 - Lys 537(N501Y) |
Appearance : |
Powder mixture |
Particle size : |
2 μm |
Bio-activity : |
Immobilized 33 μg RBD protein /1mg beads can bind ACE2 with an EC50 of 1.337 μg/mL. |
Coupled amount of protein : |
≈1194 pmol (33.8 μg) SARS-CoV-2 RBD protein/mg beads |
Capacity : |
>300 pmol (33 μg) Human ACE2 ligand/mg beads |
Formulation : |
PBS, pH7.4, with 10% Trehalose |
Reconstitution : |
2 mL sterile deionized water (1 mg beads/mL) |
Background : |
The SARS-CoV-2 Spike RBD (B.1.1.7) Coupled Magnetic Beads is produced by coupling biotinylated SARS-CoV-2 spike RBD to streptavidin-conjugated magnetic beads. The spike RBD coupled to the beads contains the critical N501Y mutation identified in multiple circulating SARS-CoV-2 variants, e.g. the U.K. variant (known as B.1.1.7, 20B/501Y.V1 or VOC 202012/01), the South African variant (known as B.1.351 or 20C/501Y.V2) and the Brazilian variant (known as P.1). The pre-coupled beads are ready to use for capturing anti-SARS-CoV-2 antibody or ACE2 protein from your sample with high specificity. |
Application : |
This product is intended for immunocapture, biopanning and flow cytometry. This product is produced non-sterile. |
Storage : |
Upon receipt, please store the Beads at -20°C for 1 year in lyophilized state. |